Boussard & Gavaudan Investment Management LLP: Form 8.3 -

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
37
Boussard & Gavaudan Investment Management LLP: Form 8.3 - RPC Group PLC

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)

1.         KEY INFORMATION

(a)  Identity of the person whose positions/dealings are being disclosed: Boussard & Gavaudan Investment Management LLP Boussard & Gavaudan Asset Management LP acting on behalf of various funds Boussard & Gavaudan Gestion
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):   The naming of nominee or vehicle companies is insufficient  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:   Use a separate form for each offeror/offeree   RPC Group Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e)  Date position held/dealing undertaken: 01 April 2019
(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer? Yes

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:   5p ordinary ISIN: GB0007197378  
    Interests Short positions
Number % Number %
(1)  Relevant securities owned and/or controlled:        
(2)  Derivatives CFD (other than options):   8,297,004 2.039%    
(3)  Options and agreements to purchase/sell:        
  TOTAL: 8,297,004 2.039%    

All interests and all short positions should be disclosed.Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors’ and other executive options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)        Purchases and sales

Class of relevant security Purchase/sale   Number of securities Price per unit
       
       

 (b)       Derivatives transactions (other than options)

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit GBP
5p ordinary CFD Increasing a long position 8 786.80

(c)        Options transactions in respect of existing securities 

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercising

Class of relevant security Product description e.g. call option Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
         

The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state “none”
     

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
     

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached ? NO
Date of disclosure:   02 April 2019
Contact name:   Deborah Gewinner
Telephone number:   +44 203 751 54 12

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk .  The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk .

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 4

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
Albertsons Welcomes Once Upon a Coconut Nationwide

Updated Category News Views 4

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 3

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Mobile Iron IV Expansions: Targeting Texas Health Needs

Updated Category News Views 13

Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 6

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 6

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading

Top 5 Most Recently Viewed Articles

UBS Enhances Azelis Rating to 'Buy' on Strong Recovery Outlook

Updated Category News Views 192

UBS Upgrades Azelis to 'Buy' Based on Positive Market Signals In a significant move for investors, UBS Global Research has upgraded Azelis Group (EBR: AZE) from a "neutral" stance to a "buy" rating. This transition comes as analysts recognize the recovery potential and favorable valuation of the Belgium-based company. Positive Market Response Following the announcement...

Continue Reading
Algae-C Inc. Merges with Rockcliffe Labs for Enhanced Biotech Growth

Updated Category News Views 192

Algae-C Inc. Merges with Rockcliffe Labs for Enhanced Biotech Growth Algae-C Inc. is now officially part of Rockcliffe Labs, a Canadian late-stage biotech innovation platform. This strategic acquisition allows Algae-C to enhance its operational capabilities and leverage Rockcliffe Labs' extensive resources and expertise in the biotechnology sector. Transaction Overview...

Continue Reading
Crown Crafts, Inc. to Discuss Q2 Fiscal 2026 Earnings Soon

Updated Category News Views 126

Crown Crafts, Inc. to Announce Q2 Fiscal 2026 Results Crown Crafts, Inc. (NASDAQ: CRWS) has made an important announcement regarding its upcoming financial results. The company plans to share its operational performance for the second quarter of fiscal year 2026 before market openings on a specified date in November 2025. This event underscores Crown Crafts’ commitment...

Continue Reading
AFGB Stock Hits 52-Week Low, Analyzing Market Trends

Updated Category News Views 256

AFGB Stock Experiences 52-Week Low Amid Market Trends American Financial Group (NYSE: AFG) has recently seen its stock, PR B (AFGB), hit a concerning 52-week low, reaching $22.7. This notable decline comes as investors contend with a fluctuating market environment that has created uncertainty among many stocks. At a market capitalization of $11.5 billion, the company's...

Continue Reading
KBR Secures $113 Million Air Force Contract for Innovation

Updated Category News Views 63

KBR Secures $113 Million Air Force Contract for Innovation KBR, Inc. (NYSE: KBR) has officially announced that it’s landed a five-year contract worth $113 million. This important contract focuses on aeronautical systems research for the Air Force Life Cycle Management Center Mobility Directorate. Purpose of the Contract Awarded under the Department of Defense...

Continue Reading